Note: This is a recording of a webinar held on May 6, 2019.
The federal government is launching an initiative to end the HIV epidemic by 1) increasing the number of US Americans who know their current HIV status, 2) increasing the number of US Americans with HIV infection who are effectively treated and have sustained viral suppression, and 3) rapid expansion and reduced racial/ethnic disparities in PrEP provision to the estimated 1.2 million US American with sexual and injection behaviors that place them as substantial risk of HIV acquisition. This webinar will discuss what PrEP is, indicators for its use and how health departments can support its expansion and effective use.
The course contains two modules: a content module and a resources and evaluation module. After accessing both modules, learners will earn a certificate of completion. When the certificate is available, learners will see a Certificate button on their dashboard.
This recording is approximately 90 minutes. There are no prerequisites. Participants will need a broadband internet connection (Google Chrome or Mozilla Firefox are preferred browsers) and computer speakers. For technical support, please contact email@example.com.
About the Trainer
Dawn K. Smith, MD, MPH, MS is the Biomedical Interventions Implementation Activity Lead in the Epidemiology Branch of the Division of HIV/AIDS Prevention at the U.S. Centers for Disease Control and Prevention (CDC). She and conducts activities supporting the implementation of daily, oral, antiretroviral preexposure prophylaxis (PrEP) and other biomedical interventions to reduce rates of new HIV infections in the US, including the development of PHS clinical practice guidelines for PrEP.
She spent 4 years as the associate director for HIV research at the CDC field station in Botswana where she established clinical trial infrastructure with integrated sociobehavioral research and initiated PrEP trials. Dr. Smith has served on scientific committees and review panels for WHO, UNAIDS, NIAID, NIDA, NIMH, the NIH Office of AIDS Research, and the Institute of Medicine. She serves on a CDC IRB and on a DSMB for the Canadian Center for Vaccinology.
This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number UB6HP31680, Public Health Training Centers for $4,348,992. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.
By the end of this webinar, participants will be able to:
- Describe PrEP care including protocols
- Identify PrEP resources
- List the indicators for PrEP prescription
- Discuss how health departments can support and monitor PrEP use for focus populations
By completing/passing this course, you will attain the certificate Certificate of Completion for Online Module
Your cart is empty